| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 5.129 | 17.532 | 2.364 | 15.697 | 13.997 | 14.018 | 13.933 | 18.007 | 26.100 | 26.059 |
| Total Income - EUR | 5.129 | 17.532 | 2.365 | 16.301 | 14.033 | 14.020 | 77.879 | 88.889 | 53.985 | 72.042 |
| Total Expenses - EUR | 2.310 | 3.401 | 6.891 | 4.665 | 1.615 | 10.665 | 67.180 | 90.508 | 57.367 | 84.482 |
| Gross Profit/Loss - EUR | 2.820 | 14.132 | -4.526 | 11.636 | 12.418 | 3.355 | 10.698 | -1.619 | -3.382 | -12.440 |
| Net Profit/Loss - EUR | 2.369 | 11.871 | -4.526 | 11.147 | 11.997 | 2.976 | 10.280 | -2.159 | -3.382 | -12.440 |
| Employees | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 |
Check the financial reports for the company - Darian Drs Evaluare Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 6.464 | 137.243 | 190.527 | 195.316 | 210.669 |
| Current Assets | 11.012 | 28.981 | 17.849 | 21.022 | 32.598 | 28.465 | 12.441 | 3.498 | 5.127 | 14.286 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 10.021 | 28.877 | 10.108 | 9.498 | 9.326 | 0 | 611 | 168 | 4.527 | 7.324 |
| Cash | 991 | 104 | 7.742 | 11.524 | 23.273 | 28.465 | 11.830 | 3.330 | 600 | 6.961 |
| Shareholders Funds | 3.424 | 15.260 | 10.476 | 21.431 | 33.013 | 35.363 | 108.850 | 107.028 | 103.322 | 90.305 |
| Social Capital | 1.125 | 1.113 | 1.095 | 1.074 | 1.054 | 1.034 | 0 | 65.203 | 65.006 | 64.642 |
| Debts | 7.970 | 13.721 | 7.745 | 87 | 75 | 74 | 41.311 | 86.997 | 97.121 | 134.651 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7022 - 7022" | |||||||||
| CAEN Financial Year |
7022
|
|||||||||
Comments - Darian Drs Evaluare Srl